Synthesis of a Novel Macrocyclic Derivatives Based on Glucopyranoside and Application as Anticancer Activity

Authors

  • Ahmed Ibrahim Hamzah Faculty of Pharmacy, Jabir Ibn Hayyan Medical University, Najaf, Iraq
  • Ibtihal Kareem Mahdi Faculty of Pharmacy, Jabir Ibn Hayyan Medical University, Najaf, Iraq

Keywords:

methyl 4,6-benzylidene-2,3-di-O-benzyl-D-glucopyranoside, PC3, pyranoside, WRL68, cancer cell lines

Abstract

Cyclic compounds have gained attention in a variety of fields for their unique properties. Crown ethers, cryptands, and calixarenes are cyclic compounds that have been used in a range of applications such as chemical sensors and drug delivery systems. Cyclic peptides have shown promise in treating various diseases due to their enhanced stability and bioavailability. This study focuses on the synthesis and characterization of a pyranoside compound, -methyl 4,6-benzylidene-2,3-di-O-benzyl-D-glucopyranoside, which was synthesized via a phase transfer catalysis method. The synthesized compound was analyzed using FT-IR, 1H NMR, and 13C NMR spectroscopy. Field-emission scanning electron microscopy and EDX analysis were also carried out to study the morphology and elemental composition of the compound. The results of this study contribute to the potential applications compounds -methyl 4,6-benzylidene-2,3-di-O-benzyl-D-glucopyranoside were evaluated for their anticancer potential against two cancer cell lines PC3 (prostate cancer cells) and WRL68 (normal liver cells) compound 12 appears to have a greater effect on prostate cancer cells (PC3) compared to compound 11. At the highest concentration tested (400 µM), compound 12 showed a mean percentage inhibition of 95.72% in PC3 cells, while compound 11 showed a mean percentage inhibition of 33.29% at the same concentration. Furthermore, the IC50 value for compound 12 in PC3 cells was 112.9 µM, while the IC50 value for compound 11 was 24.38 µM, indicating that compound 11 is less potent in inhibiting the growth of PC3 cells. These results suggest that compound 12 may have greater potential as a therapeutic agent for prostate cancer.

References

F. Ullah et al., “Fluorescent and Phosphorescent Nitrogen-Containing Heterocycles and Crown Ethers: Biological and Pharmaceutical Applications,” Molecules, vol. 27, no. 19, p. 6631, 2022.

O. Özbek, Ö. Isildak, M. B. Gürdere, and A. Cetin, “The use of crown ethers as sensor material in potentiometry technique.,” Organic Communications, vol. 14, no. 3, 2021.

A. Carvalho, P. M. Ferreira, and J. A. Martins, “New 2, 6-Bis (5-phenyloxazolyl) pyridine Ligands for Luminescent LnIII Complexes,” Chemistry Proceedings, vol. 12, no. 1, p. 56, 2022.

N. M. Helmy and K. Parang, “Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources,” Pharmaceuticals, vol. 16, no. 6, p. 892, 2023.

H. Wei et al., “Bioinspired porphyrin–peptide supramolecular assemblies and their applications,” Journal of Materials Chemistry B, vol. 10, no. 45, pp. 9334–9348, 2022.

T. A. Ramelot, J. Palmer, G. T. Montelione, and G. Bhardwaj, “Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design,” Current Opinion in Structural Biology, vol. 80, p. 102603, 2023.

G. N. Maity et al., “Structural studies of a water insoluble β-glucan from Pleurotus djamor and its cytotoxic effect against PA1, ovarian carcinoma cells,” Carbohydrate polymers, vol. 222, p. 114990, 2019.

J. Xie and N. Bogliotti, “Synthesis and Applications of Carbohydrate-Derived Macrocyclic Compounds,” 2014, doi: 10.1021/cr400035j.

P. S. Kalsi, Spectroscopy of organic compounds. New age international, 2007.

R. M. Silverstein, F. X. Webster, D. J. Kiemle, and D. L. Bryce, “Spectrometric identification of organic compounds,” in Spectrometric identification of organic compounds, 2015, p. 455.

M. Zeng, C.-L. Liu, and K. R. Wilson, “Catalytic Coupling of Free Radical Oxidation and Electrophilic Chlorine Addition by Phase-Transfer Intermediates in Liquid Aerosols,” The Journal of Physical Chemistry A, vol. 126, no. 19, pp. 2959–2965, 2022.

E. V Dehmlow, “Advances in Phase‐Transfer Catalysis [New synthetic methods (20)],” Angewandte Chemie International Edition in English, vol. 16, no. 8, pp. 493–505, 1977.

N. É. Byramova, M. V Ovchinnikov, L. V Backinowsky, and N. K. Kochetkov, “Selective removal of O-acetyl groups in the presence of O-benzoyl groups by acid-catalysed methanolysis,” Carbohydrate research, vol. 124, no. 1, pp. C8–C11, 1983.

K. J. Sabah, N. I. Zahid, and R. Hashim, “Synthesis of new chiral macrocycles-based glycolipids and its application in asymmetric Michael addition,” Research on Chemical Intermediates, vol. 47, pp. 2653–2667, 2021.

Y. Zhan et al., “One-step selective dehydrogenation of cyclic hemiacetal sugars toward to their chiral lactones,” Chinese Chemical Letters, vol. 34, no. 4, p. 107677, 2023.

D. Seebach, A. K. Beck, and D. J. Bierbaum, “The world of β‐and γ‐peptides comprised of homologated proteinogenic amino acids and other components,” Chemistry & biodiversity, vol. 1, no. 8, pp. 1111–1239, 2004.

V. K. Ahluwalia, “Different Types of Reducing Agents,” in Reduction in Organic Synthesis, Springer, 2023, pp. 3–53.

E. Marsault and M. L. Peterson, “Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery,” Journal of medicinal chemistry, vol. 54, no. 7, pp. 1961–2004, 2011.

L. T. Nguyen, H. Le Tran, P. T. Mai, V. B. Duong, L.-T. T. Nguyen, and H. T. Nguyen, “Poly (L-glutamic acid) via catalytical hydrogenation for the fabrication of carbon nanotube nanocomposites,” Materials Research, vol. 24, p. e20200321, 2021.

B. Elamin, G. M. Anantharamaiah, G. P. Royer, and G. E. Means, “Removal of benzyl-type protecting groups from peptides by catalytic transfer hydrogenation with formic acid,” The Journal of Organic Chemistry, vol. 44, no. 19, pp. 3442–3444, 1979.

M. M. Matin and M. Z. Iqbal, “Methyl 4-O-(2-chlorobenzoyl)-α-L-rhamnopyranosides: Synthesis, characterization, and thermodynamic studies,” Orbital: The Electronic Journal of Chemistry, pp. 19–27, 2021.

A. Oberlintner, B. Likozar, and U. Novak, “Hydrophobic functionalization reactions of structured cellulose nanomaterials: Mechanisms, kinetics and in silico multi-scale models,” Carbohydrate Polymers, vol. 259, p. 117742, 2021.

J. Ali et al., “A new biosource for synthesis of activated carbon and its potential use for removal of methylene blue and eriochrome black T from aqueous solutions,” Industrial Crops and Products, vol. 179, p. 114676, 2022.

H. M. Aliabadi and K. Zargoosh, “Synthesis of 3-amino-1, 2, 4-triazole-5-thiol functionalized p-phenylenediamine covalent organic polymer as a highly selective adsorbent for Hg2+ ions,” Reactive and Functional Polymers, vol. 186, p. 105575, 2023.

H. Montes-Andrés et al., “Synthesis, Structural Features, and Hydrogen Adsorption Properties of Three New Flexible Sulfur-Containing Metal–Organic Frameworks,” Crystal Growth & Design, vol. 20, no. 10, pp. 6707–6714, Oct. 2020, doi: 10.1021/acs.cgd.0c00857.

Q. Cheng et al., “Li+-ion bound crown ether functionalization enables dual promotion of dynamics and thermodynamics for ambient ammonia synthesis,” Journal of Energy Chemistry, 2023.

A. Rawat and A. V. B. Reddy, “Recent advances on anticancer activity of coumarin derivatives,” European Journal of Medicinal Chemistry Reports, vol. 5, p. 100038, 2022.

Z. M. Noufal, P. Sivaperumal, and P. Elumalai, “Extraction, characterization, and anticancer potential of extracellular polymeric substances from marine actinobacteria of Streptomyces species,” Journal of advanced pharmaceutical technology & research, vol. 13, no. Suppl 1, p. S125, 2022.

R. A. Ali, E. O. Al-Tamimi, and S. A. Wadood, “Synthesis and Characterization of New 1, 3, 4-Oxadiazole Ring on Creatinine Derivatives Using Iodine and Study Their Anticancer Effect,” Russian Journal of Bioorganic Chemistry, pp. 1–3, 2023.

A. T. Odularu, “Manganese Schiff base complexes, crystallographic studies, anticancer activities, and molecular docking,” Journal of Chemistry, vol. 2022, 2022.

Downloads

Published

2024-04-25

How to Cite

Hamzah, A. I. ., & Mahdi, I. K. . (2024). Synthesis of a Novel Macrocyclic Derivatives Based on Glucopyranoside and Application as Anticancer Activity. Procedia of Engineering and Medical Sciences, 9(2), 19–38. Retrieved from https://procedia.online/index.php/engineering/article/view/1381

Issue

Section

Articles